Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries

個数：

電子版価格
¥18,426

電子版あり

Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries

Harpum, Pete (EDT)

ウェブストア価格 ¥28,854（本体¥26,231）
John Wiley & Sons Inc（2010/04発売）
外貨定価 US$ 136.95
ポイント 262pt

提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合が若干ございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Hardcover:ハードカバー版／ページ数 331 p.
言語 ENG
商品コード 9780470049662
DDC分類 615.10684

Full Description

This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly experienced practitioners from within the industry on future directions for drug program management. The book integrates portfolio, program, and project management processes as fundamental for effective and efficient drug product development. Contributing expert authors provide their view of how the projectization approach can be taken forward by the drug industry over the coming years.

Preface ix

Acknowledgments xi

About the Authors xiii

Part One The Life Science Industry Context for Portfolio, Program, and Project Management

1. A Review of Project Management in Life Science Industry Sectors 3
Thomas R. Dunson

2. The Impact of Organizational Size on Drug Project Management 21
Eric Morfin

3. Drug Development in Biotechnology and How We Can Do It Better 33
Susan Linna

Part Two The Portfolio, Program, and Project Management Approaches and Processes

4. An Overview of the Organization and Processes of Portfolio, Program, and Project Management 53
Pete Harpum

5. Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market 59
John Bennett

6. Program Management in Drug Development 85
Pauline Stewart-Long

7. Project Control 101
Martin Powell

8. Managing Uncertainty in Drug Projects 135
Pete Harpum and Thomas R. Dunson

9. Managing Drug Safety Risk 155
Thomas R. Dunson and Eric Morfin

10. Developing Program Strategy 175
Pete Harpum

11. Developing Products with "Added Value" 197
Trevor J. Brown and Stephen Allport

Part Three Integrating the Processes

12. Integrated Business Processes to Support Cross-Functional Drug Development 227
Martin D. Hynes III

13. Integrated Drug Development: From Cradle to Grave and from Lab to Market 239
Stephen Allport and Terry Cooke-Davies

14. The Development of P3M Capability in Drug Development Organizations 259
John Arrowsmith, Patrick Grogan, and Bob Moore

15. Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations 287
Pete Harpum, Ashley Jamieson, and Inge Fisher

Bibliography 311

Index 313